Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ACHC Stock Forecast 2025-2026
$15.47
Current Price
$1.43B
Market Cap
Buy 8
Hold 5
Sell 1
Wall St Analyst Ratings
Distance to ACHC Price Targets
+119.8%
To High Target of $34.00
+45.4%
To Median Target of $22.50
-16.0%
To Low Target of $13.00
ACHC Price Momentum
-10.1%
1 Week Change
-20.7%
1 Month Change
-62.4%
1 Year Change
-61.0%
Year-to-Date Change
-67.1%
From 52W High of $47.08
+22.5%
From 52W Low of $12.63
📊 TOP ANALYST CALLS
Did ACHC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Acadia Healthcare is one of their latest high-conviction picks.
Latest ACHC Stock Price Targets & Analyst Predictions
Based on our analysis of 26 Wall Street analysts, ACHC has a bullish consensus with a median price target of $22.50 (ranging from $13.00 to $34.00). The overall analyst rating is Buy (7.9/10). Currently trading at $15.47, the median forecast implies a 45.4% upside. This outlook is supported by 8 Buy, 5 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Kevin Fischbeck at B of A Securities, suggesting a 16.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ACHC Analyst Ratings
8
Buy
5
Hold
1
Sell
ACHC Price Target Range
Low
$13.00
Average
$22.50
High
$34.00
Current: $15.47
Latest ACHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ACHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 4, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $14.00 |
| Dec 3, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $19.00 |
| Dec 3, 2025 | UBS | Andrew Mok | Buy | Maintains | $24.00 |
| Dec 3, 2025 | Leerink Partners | Whit Mayo | Market Perform | Downgrade | $14.00 |
| Dec 3, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Maintains | $17.00 |
| Dec 3, 2025 | B of A Securities | Kevin Fischbeck | Underperform | Downgrade | $13.00 |
| Dec 3, 2025 | Deutsche Bank | Pito Chickering | Buy | Maintains | $20.00 |
| Dec 3, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $25.00 |
| Nov 18, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $30.00 |
| Nov 12, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $22.00 |
| Nov 10, 2025 | Guggenheim | Jason Cassorla | Buy | Maintains | $27.00 |
| Nov 7, 2025 | UBS | Andrew Mok | Buy | Maintains | $28.00 |
| Nov 7, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Maintains | $22.00 |
| Nov 6, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $17.00 |
| Oct 8, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $35.00 |
| Oct 7, 2025 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $25.00 |
| Oct 3, 2025 | Raymond James | John Ransom | Outperform | Maintains | $30.00 |
| Sep 10, 2025 | B of A Securities | Joanna Gajuk | Neutral | Downgrade | $25.00 |
| Aug 14, 2025 | Mizuho | Ann Hynes | Neutral | Maintains | $22.00 |
| Aug 14, 2025 | Raymond James | John Ransom | Outperform | Downgrade | $26.00 |
Acadia Healthcare Company, Inc. (ACHC) Competitors
The following stocks are similar to Acadia Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ACHC
Acadia Healthcare
mkt cap
1.43B
Acadia Healthcare Company, Inc. (ACHC) Financial Data
Acadia Healthcare Company, Inc. has a market capitalization of $1.43B with a P/E ratio of 13.3x. The company generates $3.27B in trailing twelve-month revenue with a 3.3% profit margin.
Revenue growth is +4.4% quarter-over-quarter, while maintaining an operating margin of +14.0% and return on equity of +3.7%.
Valuation Metrics
Market Cap
$1.43B
Enterprise Value
$3.93B
P/E Ratio
13.3x
PEG Ratio
-0.3x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+4.4%
Gross Margin
+96.4%
Operating Margin
+14.0%
Net Margin
+3.3%
EPS Growth
-46.8%
Financial Health
Cash/Price Ratio
+8.3%
Current Ratio
1.4x
Debt/Equity
74.5x
ROE
+3.7%
ROA
+4.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Acadia Healthcare Company, Inc. (ACHC) Business Model
About Acadia Healthcare Company, Inc.
What They Do
Provides behavioral healthcare services in the US and UK.
Business Model
Acadia Healthcare generates revenue by operating a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic programs. The company focuses on mental health and addiction treatment, catering to a growing demand for these services as societal stigma decreases and the need for quality care increases.
Additional Information
Acadia Healthcare is dedicated to addressing the needs of underserved populations and works with government health agencies to enhance access to mental health services. Its comprehensive approach and commitment to quality care position it as a key player in the expanding healthcare market.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
19,192
CEO
Mr. Christopher Howal Hunter
Country
United States
IPO Year
1994
Website
www.acadiahealthcare.comAcadia Healthcare Company, Inc. (ACHC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Acadia Healthcare (ACHC) Down 27.7% Since Last Earnings Report: Can It Rebound?
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Dec 05, 2025
By Zacks Equity Research
Realtime BLOG
Acadia Healthcare Cuts 2025 Outlook After Liability Bomb Went Off
ACHC cuts its 2025 outlook as liability costs soar, with surging claims and weaker reinsurance sharply hitting earnings and EBITDA.
Dec 03, 2025
By Kaibalya Pravo Dey
Analyst Blog
Latest News
Quick Summary
Glancy Prongay & Murray LLP has initiated an investigation into Acadia Healthcare Company (NASDAQ: ACHC) for potential violations of federal securities laws affecting investors.
Why It Matters
The investigation into Acadia Healthcare for potential securities law violations may impact investor confidence and stock performance, signaling possible legal challenges and financial risks.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Acadia Healthcare (ACHC) shares fell over 10% following a downgrade to 'Underperform' by Bank of America, citing rising costs impacting profitability until 2026 and a price target of $13.
Why It Matters
Acadia Healthcare's downgrade signals potential profitability issues due to rising costs, leading to a significant drop in share value and a lowered price target, impacting investor sentiment.
Source: Proactive Investors
Market Sentiment:
Negative
Quick Summary
The Law Offices of Frank R. Cruz is investigating Acadia Healthcare Company (NASDAQ: ACHC) for potential violations of federal securities laws affecting investors.
Why It Matters
The investigation into Acadia Healthcare for potential securities law violations could indicate financial instability or mismanagement, raising concerns about stock value and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The Law Offices of Howard G. Smith are investigating Acadia Healthcare Company, Inc. (NASDAQ: ACHC) for potential violations of federal securities laws. Investors who suffered losses are encouraged to contact the firm.
Why It Matters
The investigation into Acadia Healthcare for potential securities law violations could signal legal issues ahead, impacting stock value and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
ACHC has lowered its 2025 outlook due to rising liability costs, increased claims, and weaker reinsurance, significantly impacting earnings and EBITDA.
Why It Matters
ACHC's reduced 2025 outlook signals rising liability costs and declining profitability, which may lead to lower investor confidence and potential stock price declines.
Source: Zacks Investment Research
Market Sentiment:
Negative
Acadia Healthcare Updates PLGL Reserves Following Annual Actuarial Review, Lowers 2025 Guidance
4 days ago
Quick Summary
Acadia Healthcare (NASDAQ: ACHC) updated its professional and general liability reserves due to higher anticipated litigation costs, projecting 2025 Adjusted EBITDA between $601M and $611M.
Why It Matters
Acadia's reserve update signals increased litigation costs, impacting future profitability and Adjusted EBITDA forecasts, which can influence investor sentiment and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About ACHC Stock
What is Acadia Healthcare Company, Inc.'s (ACHC) stock forecast for 2026?
Based on our analysis of 26 Wall Street analysts, Acadia Healthcare Company, Inc. (ACHC) has a median price target of $22.50. The highest price target is $34.00 and the lowest is $13.00.
Is ACHC stock a good investment in 2026?
According to current analyst ratings, ACHC has 8 Buy ratings, 5 Hold ratings, and 1 Sell ratings. The stock is currently trading at $15.47. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ACHC stock?
Wall Street analysts predict ACHC stock could reach $22.50 in the next 12 months. This represents a 45.4% increase from the current price of $15.47. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Acadia Healthcare Company, Inc.'s business model?
Acadia Healthcare generates revenue by operating a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic programs. The company focuses on mental health and addiction treatment, catering to a growing demand for these services as societal stigma decreases and the need for quality care increases.
What is the highest forecasted price for ACHC Acadia Healthcare Company, Inc.?
Price targets from Wall Street analysts for ACHC are not currently available. The stock is trading at $15.47.
What is the lowest forecasted price for ACHC Acadia Healthcare Company, Inc.?
The lowest price target for ACHC is $13.00 from Kevin Fischbeck at B of A Securities, which represents a -16.0% decrease from the current price of $15.47.
What is the overall ACHC consensus from analysts for Acadia Healthcare Company, Inc.?
The overall analyst consensus for ACHC is bullish. Out of 26 Wall Street analysts, 8 rate it as Buy, 5 as Hold, and 1 as Sell, with a median price target of $22.50.
How accurate are ACHC stock price projections?
Stock price projections, including those for Acadia Healthcare Company, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 7, 2025 5:11 AM UTC